Last $29.49 USD
Change Today +0.28 / 0.96%
Volume 21.9M
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 4:15 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Liza Page Nelson

AgeTotal Calculated CompensationThis person is connected to 41 board members in 4 different organizations across 7 different industries.

See Board Relationships
52--

Background*

Ms. Liza Page Nelson served as a Venture Partner at Investor Growth Capital. Ms. Nelson has been with the firm since 1998. From 1988 to 2009, she served as the Co-Head of the firm’s Healthcare investing activities as a Managing Director with a focus on specialty, small molecule and biologic pharmaceuticals and healthcare services. Previously, Ms. Nelson spent ten years at Pfizer Inc, where she held a series of positions with increasing responsibility in corporate finance ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Director
Former Director
Former Director
Former Director
Former Director
Director
Director
2002-N/A
Former Director and Chairman of Nominating and Corporate Governance Committee
2008-Present
Director

Education*

MBA
Yale University
BA
Wesleyan University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $29.49 USD +0.28

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman of the Board, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$1.8M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.